Insmed (INSM) Change in Accured Expenses (2010 - 2026)

Insmed (INSM) recorded quarterly Change in Accured Expenses of -$497000.0 in Q1 2026, up 96.62% quarter-over-quarter from -$14.7 million in Q4 2025, and up 99.19% on a YoY basis from -$249508.3 in Q1 2025.

Insmed (INSM) Change in Accured Expenses (2010 - 2026) Analysis & Trends

Insmed's Change in Accured Expenses history runs 17 years deep, the most recent figure standing at -$497000.0 for Q1 2026.

  • In Q1 2026, Change in Accured Expenses rose 99.19% year-over-year to -$497000.0; the TTM figure through Mar 2026 stood at $56.0 million (up 620.75% YoY), while the FY2025 annual figure was -$5.0 million, down 111.19% from the prior year.
  • Change in Accured Expenses was -$497000.0 for Q1 2026 at Insmed, up from -$14.7 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $58.5 million in Q2 2025 to a low of -$61.5 million in Q1 2025.
  • Historically, Change in Accured Expenses has averaged $2.5 million across 5 years, with a median of $725000.0 in 2024.
  • Biggest YoY gain for Change in Accured Expenses was 1652.97% in 2025; the steepest drop was 900.81% in 2025.
  • A 5-year view of Change in Accured Expenses shows it stood at -$27.7 million in 2022, then soared by 178.31% to $21.7 million in 2023, then soared by 89.46% to $41.1 million in 2024, then plunged by 135.79% to -$14.7 million in 2025, then jumped by 96.62% to -$497000.0 in 2026.
  • The last three Change in Accured Expenses figures came in at -$497000.0 (Q1 2026), -$14.7 million (Q4 2025), and $12.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - 931,000.00
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - 644,700.00
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 70.50 Mn
9 Abivax 91.71 Bn 91.71 Bn - -
10 Insmed 19.79 Bn 18.57 Bn 258.54 Mn -497,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -497,000.00
Mar 31, 2026 -497,000.00
Dec 31, 2025 -14.72 Mn
Dec 31, 2025 -14.72 Mn
Sep 30, 2025 12.71 Mn
Sep 30, 2025 12.71 Mn
Jun 30, 2025 58.51 Mn
Jun 30, 2025 58.51 Mn
Mar 31, 2025 -61.49 Mn
Mar 31, 2025 -61.49 Mn
Dec 31, 2024 41.13 Mn
Dec 31, 2024 41.13 Mn
Sep 30, 2024 725,000.00
Sep 30, 2024 725,000.00
Jun 30, 2024 8.88 Mn
Jun 30, 2024 8.88 Mn
Mar 31, 2024 -6.14 Mn
Mar 31, 2024 -6.14 Mn
Dec 31, 2023 21.71 Mn
Dec 31, 2023 21.71 Mn